In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Proteus Digital Health gets $50mm via Series H

Executive Summary

Digital medicine firm Proteus Digital Health Inc. raised $50mm in its Series H financing round to unnamed backers. The company will use the proceeds to increase the presence of its Proteus Discover product, which consists of a sensor-enabled pill, small wearable patch, and applications that can be accessed via mobile devices and computers by patients and healthcare providers. Proteus closed a $172mm Series G financing in 2014.

Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Medical Devices
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Biosensors
  • Biotechnology
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register